Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia

European Journal of Clinical Pharmacology

Volumn 67, Issue 4, 2011, Pages 383-388

  Lai, I Ching ^a,b   Mo, Geng Han ^c   Chen, Mao Liang ^a   Wang, Ying Chieh ^b,d   Chen, Jen Yeu ^d   Liao, Ding Lieh ^e   Bai, Ya Mei ^f   Lin, Chao Cheng ^g   Chen, Tzu Ting ^d   Liou, Ying Jay ^f,h  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d YULI VETERANS HOSPITAL   (Taiwan)

^e Pali Psychiatric Hospital   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Dopamine receptor; DRD1; Genotype; Haplotype; Schizophrenia; Tardive dyskinesia

Indexed keywords

CHLORPROMAZINE; DOPAMINE 1 RECEPTOR; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; SULPIRIDE; ZUCLOPENTHIXOL;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; ARTICLE; CONTROLLED STUDY; DRD1 GENE; DRUG INDUCED DISEASE; DYSKINESIA; EXCITATORY JUNCTION POTENTIAL; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TARDIVE DYSKINESIA; TREATMENT DURATION;

ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D1; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 79954599729     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0967-2     Document Type: Article

References (20)

1. Guy W (1976) ECDEU Assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, pp 534-537
2. NR Schooler JM Kane 1982 Research diagnoses for tardive dyskinesia Arch Gen Psychiatry 39 4 486 487 6121550 1:STN:280:DyaL387lvFCntA%3D%3D (Pubitemid 12152819)
3. JM Smith RJ Baldessarini 1980 Changes in prevalence, severity, and recovery in tardive dyskinesia with age Arch Gen Psychiatry 37 12 1368 1373 6108750 1:STN:280:DyaL3M%2FosFeitw%3D%3D (Pubitemid 11204075)
4. JB Penney Jr AB Young 1983 Speculations on the functional anatomy of basal ganglia disorders Annu Rev Neurosci 6 73 94 6838141 10.1146/annurev.ne.06. 030183.000445 (Pubitemid 13101459)
5. JB Penney Jr AB Young 1986 Striatal inhomogeneities and basal ganglia function Mov Disord 1 1 3 15 2848190 10.1002/mds.870010102
6. DG Morgan JO Marcusson P Nyberg P Wester B Winblad MN Gordon CE Finch 1987 Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging Neurobiol Aging 8 3 195 201 3600950 10.1016/0197-4580(87)90002-9 1:CAS:528:DyaL2sXksFakur4%3D (Pubitemid 17111020)
7. J Gerlach DE Casey 1988 Tardive dyskinesia Acta Psychiatr Scand 77 4 369 378 2898870 10.1111/j.1600-0447.1988.tb05138.x 1:STN:280:DyaL1c3ms1yhtA%3D%3D
8. DE Casey 1999 Tardive dyskinesia and atypical antipsychotic drugs Schizophr Res 35 Suppl S61 S66 10190226 10.1016/S0920-9964(98)00160-1 (Pubitemid 29133026)
9. NR Schooler JM Kane 1982 Research diagnoses for tardive dyskinesia Arch Gen Psychiatry 39 4 486 487 6121550 1:STN:280:DyaL387lvFCntA%3D%3D (Pubitemid 12152819)
10. V Dolzan BK Plesnicar A Serretti L Mandelli B Zalar J Koprivsek K Breskvar 2007 Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment Am J Med Genet B Neuropsychiatr Genet 144B 6 809 815 10.1002/ajmg.b.30544 17455212 10.1002/ajmg.b.30544 1:CAS:528:DC%2BD2sXhtFamsrrF (Pubitemid 47417211)
11. V Srivastava PG Varma S Prasad P Semwal VL Nimgaonkar B Lerer SN Deshpande T Bk 2006 Genetic susceptibility to tardive dyskinesia among schizophrenia subjects. IV. Role of dopaminergic pathway gene polymorphisms Pharmacogenet Genomics 16 2 111 117 16424823 10.1097/01.fpc.0000184957.98150.0f 1:CAS:528:DC%2BD28Xls1Gksw%3D%3D (Pubitemid 43145679)
12. W Huang JZ Ma TJ Payne J Beuten RT Dupont MD Li 2008 Significant association of DRD1 with nicotine dependence Hum Genet 123 2 133 140 18092181 10.1007/s00439-007-0453-9 1:CAS:528:DC%2BD1cXitVSqsr4%3D
13. W Dupont W Plummer 1997 PS power and sample size program available for free on the internet Control Clin Trials 18 274 10.1016/S0197-2456(97)00074-3
14. RH Segman T Goltser U Heresco-Levy B Finkel R Shalem M Schlafman A Yakir D Greenberg R Strous A Lerner A Shelevoy B Lerer 2003 Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia Pharmacogenomics J 3 5 277 283 14583797 10.1038/sj.tpj.6500194 1:CAS:528:DC%2BD3sXosVOhsr8%3D (Pubitemid 37428193)
15. C Guzey MG Scordo E Spina VM Landsem O Spigset 2007 Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms Eur J Clin Pharmacol 63 3 233 241 17225991 10.1007/s00228-006-0234-8 (Pubitemid 46233150)
16. M Sato M Soma T Nakayama K Kanmatsuse 2000 Dopamine D1 receptor gene polymorphism is associated with essential hypertension Hypertension 36 2 183 186 10948075 1:CAS:528:DC%2BD3cXmtlers7s%3D (Pubitemid 30626986)
17. NC Allen S Bagade MB McQueen JP Ioannidis FK Kavvoura MJ Khoury RE Tanzi L Bertram 2008 Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database Nat Genet 40 7 827 834 18583979 10.1038/ng.171 1:CAS:528:DC%2BD1cXnslKku7w%3D (Pubitemid 351913655)
18. MW Jann 1991 Clozapine Pharmacotherapy 11 3 179 195 1677765 1:STN:280:DyaK3MzhvFKjsQ%3D%3D
19. JH Friedman 2004 Historical perspective on movement disorders J Clin Psychiatry 65 Suppl 9 3 8 15189105
20. S Cichon MM Nothen G Stober R Schroers M Albus W Maier M Rietschel J Korner B Weigelt E Franzek D Wildenauer R Fimmers P Propping 1996 Systematic screening for mutations in the 5'-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder Am J Med Genet 67 4 424 428 8837716 10.1002/(SICI)1096-8628(19960726) 67:4<424::AID-AJMG21>3.0.CO;2-K 1:STN:280:DyaK28vjsVOqsA%3D%3D (Pubitemid 26256012)